Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunohistochemical Analysis of PD-L1 Expression in Canine Malignant Cancers and PD-1 Expression on Lymphocytes in Canine Oral Melanoma
Authors
Keywords
Dogs, Melanomas, Adenocarcinomas, Immunohistochemistry techniques, Cancer treatment, Flow cytometry, Prostate gland, Carcinomas
Journal
PLoS One
Volume 11, Issue 6, Pages e0157176
Publisher
Public Library of Science (PLoS)
Online
2016-06-09
DOI
10.1371/journal.pone.0157176
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prevalence of tumor-infiltrating lymphocytes and PD-L1 expression in the soft tissue sarcoma microenvironment
- (2015) Sandra P. D’Angelo et al. HUMAN PATHOLOGY
- Enhanced T-Cell Immunity to Osteosarcoma Through Antibody Blockade of PD-1/PD-L1 Interactions
- (2015) Danielle M. Lussier et al. JOURNAL OF IMMUNOTHERAPY
- Association of PD-1, PD-1 Ligands, and Other Features of the Tumor Immune Microenvironment with Response to Anti-PD-1 Therapy
- (2014) J. M. Taube et al. CLINICAL CANCER RESEARCH
- Influence of PD-L1 cross-linking on cell death in PD-L1-expressing cell lines and bovine lymphocytes
- (2014) Ryoyo Ikebuchi et al. IMMUNOLOGY
- Expression of PD-L1 on Canine Tumor Cells and Enhancement of IFN-γ Production from Tumor-Infiltrating Cells by PD-L1 Blockade
- (2014) Naoya Maekawa et al. PLoS One
- What do we know about canine osteosarcoma treatment? – review
- (2014) M. Szewczyk et al. VETERINARY RESEARCH COMMUNICATIONS
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- Antagonist Antibodies to PD-1 and B7-H1 (PD-L1) in the Treatment of Advanced Human Cancer
- (2013) M. Sznol et al. CLINICAL CANCER RESEARCH
- Programmed Death 1-Mediated T Cell Exhaustion during Visceral Leishmaniasis Impairs Phagocyte Function
- (2013) K. J. Esch et al. JOURNAL OF IMMUNOLOGY
- Tumor Infiltrating PD1-Positive Lymphocytes and the Expression of PD-L1 Predict Poor Prognosis of Soft Tissue Sarcomas
- (2013) Jung Ryul Kim et al. PLoS One
- Phase I Study of Single-Agent Anti–Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates
- (2010) Julie R. Brahmer et al. JOURNAL OF CLINICAL ONCOLOGY
- Methods and mortality results of a health survey of purebred dogs in the UK
- (2010) V. J. Adams et al. JOURNAL OF SMALL ANIMAL PRACTICE
- Data from the Danish Veterinary Cancer Registry on the occurrence and distribution of neoplasms in dogs in Denmark
- (2010) L. B. Bronden et al. VETERINARY RECORD
- Cancer Incidence in Pet Dogs: Findings of the Animal Tumor Registry of Genoa, Italy
- (2009) D.F. Merlo et al. JOURNAL OF VETERINARY INTERNAL MEDICINE
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Canine mast cell tumours: a review of the pathogenesis, clinical features, pathology and treatment
- (2008) Monika M. Welle et al. VETERINARY DERMATOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now